Medicines Discovery Catapult and the Francis Crick Institute Partner to Support KQ Labs, a Leading Accelerator for Life Sciences Innovators

Selvita Acquires License for Medicines Discovery Catapult’s Patented Target Engagement Technology

The Chemical Protein Stability Assay generates vital data to support drug discovery innovators and will enhance Selvita’s screening platform

MDC achieves ISO 45001 health and safety standard

MDC has been awarded ISO 45001, an international standard for occupational health and safety.

Medicines Discovery Catapult Wins Bionow Business Support Award

MDC is recognised for its support of the Life Sciences sector

Commercialisation Pathway Simplified with New Regulatory Roadmap for RNA Therapeutics and Vaccines

Intracellular Drug Delivery Centre has developed the go-to guide with input from MHRA

New Funding Available to Mental Health Drug Discovery Innovators

Wellcome, in collaboration with MDC’s Psychiatry Consortium, launches funding call to support mental health drug innovators

Scientific Experts Join Medicines Discovery Catapult’s Board of Directors

New Board members bring diverse additional life science expertise to MDC

MDC Publishes First Year of ESG Progress

Reshaping drug discovery, responsibly

Turning Nuclear Waste into Breakthrough Cancer Treatments

Funding awarded by UKRI to explore sustainable manufacturing of new targeted radiotherapy treatments that could improve patient outcomes